Dermata Therapeutics, Inc. - DRMA
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | History | Reduced | 322,179 | 188 | 0.0% | 0.01% | 1 | -88,821 | -21.61% | Q2 2025 | Aug 14, 2025 |
| UBS Group AG | History | Added to | 90,955 | 53 | 0.0% | 0.0% | 2 | +20,665 | 29.4% | Q2 2025 | Aug 14, 2025 |
| XTX Topco Ltd | History | New | 34,492 | 20 | 0.0% | — | 3 | +34,492 | New | Q2 2025 | Aug 12, 2025 |
| GEODE CAPITAL MANAGEMENT, LLC | History | Added to | 27,385 | 16 | 0.0% | 0.0% | 4 | +6,979 | 34.2% | Q2 2025 | Aug 08, 2025 |
| TWO SIGMA SECURITIES, LLC | History | New | 14,724 | 8 | 0.0% | — | 5 | +14,724 | New | Q2 2025 | Aug 14, 2025 |
| JONES FINANCIAL COMPANIES LLLP | History | No change | 12,000 | 7 | 0.0% | 0.0% | 6 | 0 | 0.0% | Q2 2025 | Aug 13, 2025 |
| Tower Research Capital LLC (TRC) | History | Added to | 5,318 | 3 | 0.0% | 0.0% | 7 | +3,522 | 196.1% | Q2 2025 | Aug 15, 2025 |
| WELLS FARGO & COMPANY/MN | History | Closed out | 0 | 0 | — | 0.0% | — | -2,000 | -100.0% | Q2 2025 | Aug 14, 2025 |
| CITIGROUP INC | History | New | 60 | 0 | — | — | — | +60 | New | Q2 2025 | Aug 11, 2025 |
| BANK OF AMERICA CORP /DE/ | History | Added to | 31 | 0 | — | — | — | +10 | 47.62% | Q2 2025 | Aug 14, 2025 |
| SBI Securities Co., Ltd. | History | Added to | 1,010 | 0 | — | 0.0% | — | +10 | 1.0% | Q2 2025 | Aug 08, 2025 |